Maven Income & Growth VCT 3 Ord Stocks

£ 44.4Last Updated 15.04.2026

Issuer Rating

2/7
Performance

Modest

Risk

High

Recommendation

Sell

Market Cap

£ 90.20M

Buy
Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
£ 44.4
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly overvalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Maven Income and Growth VCT 3 PLC is a venture capital trust fund specializing in development capital and early stage investments. In case of private companies, the fund prefers to invest in later stage. It does not invest in hostile public to private transactions. The fund's objective is to achieve long-term capital appreciation principally through investment in smaller unquoted companies and AIM quoted companies in the United Kingdom with strong growth potential. It invests up to £1million ($1.65 million) in any company in one year and no more than 15 percent of the company's assets by cost in one business at any time. The fund seeks to take a Non-Executive Board seat on its investee companies. It may co-invest in case of larger deals.

Company Valuation

Greatly overvalued
1/7

Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers. Specifically, the stock is 'expensive' on P/E, overvalued on EV/EBITD.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks